|
Q3 2018
|
2 |
8,905 |
ADMA, MABVAX THERAPEUTICS HOLDINGS, INC.
|
13F-HR
|
10/24/2018 |
000095012318010111 |
|
Q2 2018
|
2 |
6,472 |
ADMA, MABVAX THERAPEUTICS HOLDINGS, INC.
|
13F-HR
|
8/9/2018 |
000095012318007745 |
|
Q1 2018
|
2 |
6,606 |
ADMA, MABVAX THERAPEUTICS HOLDINGS, INC.
|
13F-HR
|
4/20/2018 |
000095012318003690 |
|
Q4 2017
|
3 |
89,831 |
JUNO, ADMA, MABVAX THERAPEUTICS HOLDINGS, INC.
|
13F-HR
|
2/13/2018 |
000095012318001663 |
|
Q3 2017
|
3 |
88,059 |
JUNO, ADMA, MABVAX THERAPEUTICS HOLDINGS, INC.
|
13F-HR
|
10/30/2017 |
000095012317009332 |
|
Q2 2017
|
3 |
61,060 |
JUNO, ADMA, MABVAX THERAPEUTICS HOLDINGS, INC.
|
13F-HR
|
8/8/2017 |
000095012317006869 |
|
Q1 2017
|
3 |
55,177 |
JUNO, ADMA, MABVAX THERAPEUTICS HOLDINGS, INC.
|
13F-HR
|
5/11/2017 |
000095012317004503 |
|
Q4 2016
|
3 |
48,307 |
JUNO, ADMA, MABVAX THERAPEUTICS HOLDINGS, INC.
|
13F-HR
|
2/13/2017 |
000095012317001771 |
|
Q3 2016
|
3 |
75,570 |
JUNO, ADMA, MABVAX THERAPEUTICS HOLDINGS, INC.
|
13F-HR
|
11/9/2016 |
000095012316021416 |
|
Q2 2016
|
3 |
77,937 |
JUNO, ADMA, MABVAX THERAPEUTICS HOLDINGS, INC.
|
13F-HR
|
8/12/2016 |
000095012316019699 |
|
Q1 2016
|
3 |
72,779 |
JUNO, ADMA, MABVAX THERAPEUTICS HOLDINGS, INC.
|
13F-HR
|
6/1/2016 |
000095012316017825 |
|
Q4 2015
|
3 |
82,168 |
JUNO, ADMA, MABVAX THERAPEUTICS HOLDINGS, INC.
|
13F-HR
|
2/16/2016 |
000095012316015118 |